Inmolecule Nanotech (XPAR:MLINA) Total Liabilities: €4.85 Mil (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Total Liabilities?

Inmolecule Nanotech XPAR:MLINA 6 Total Liabilities is €4.85 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Total Liabilities for the quarter that ended in Dec. 2024 was €4.85 Mil.

Inmolecule Nanotech's quarterly Total Liabilities increased from . 20 (€0.00 Mil) to Dec. 2023 (€5.81 Mil) but then declined from Dec. 2023 (€5.81 Mil) to Dec. 2024 (€4.85 Mil).

Inmolecule Nanotech's annual Total Liabilities increased from . 20 (€0.00 Mil) to Dec. 2023 (€5.81 Mil) but then declined from Dec. 2023 (€5.81 Mil) to Dec. 2024 (€4.85 Mil).

Inmolecule Nanotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Total Liabilities Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Total Liabilities
5.81 4.85

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Total Liabilities 5.81 4.85
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inmolecule Nanotech's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.908+(1.938+-0.0010000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.85

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=12.303-7.458
=4.85

Inmolecule Nanotech's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.908+(1.938+-0.0010000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.85

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=12.303-7.458
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €4.85 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Total Liabilities of €4.85 Mil as of Dec. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Total Liabilities too high?
Inmolecule Nanotech's current Total Liabilities is €4.85 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Total Liabilities compare to VRTX and REGN?
Inmolecule Nanotech's Total Liabilities of €4.85 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Total Liabilities is €4.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Total Liabilities of €4.85 Mil. The current Total Liabilities is €4.85 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Total Liabilities is €4.85 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price